XML 33 R14.htm IDEA: XBRL DOCUMENT v3.8.0.1
Earnings Per Share
3 Months Ended
Mar. 31, 2018
Earnings Per Share [Abstract]  
Earnings Per Share Disclosure









8.  EARNINGS PER SHARE 

The following table sets forth the components of the numerator and denominator for the computation of basic and diluted (loss) earnings per share for loss from continuing operations, discontinued operations and net loss attributable to Community Health Systems, Inc. common stockholders (in millions, except share data):



 

 

 

 

 



 

 

 

 

 



Three Months Ended



March 31,

 

2018

 

2017

Numerator:

 

 

 

 

 

Loss from continuing operations, net of taxes

$

(6)

 

$

(176)

Less: Income from continuing operations attributable

 

 

 

 

 

to noncontrolling interests, net of taxes

 

19 

 

 

22 

Loss from continuing operations attributable to

 

 

 

 

 

Community Health Systems, Inc. common

 

 

 

 

 

stockholders — basic and diluted

$

(25)

 

$

(198)



 

 

 

 

 

Loss from discontinued operations, net of taxes

$

 -

 

$

(1)

Less: Loss from discontinued operations attributable

 

 

 

 

 

to noncontrolling interests, net of taxes

 

 -

 

 

 -

Loss from discontinued operations attributable to

 

 

 

 

 

Community Health Systems, Inc. common

 

 

 

 

 

stockholders — basic and diluted

$

 -

 

$

(1)



 

 

 

 

 

Denominator:

 

 

 

 

 

Weighted-average number of shares outstanding — basic

 

112,291,496 

 

 

111,252,331 

Effect of dilutive securities:

 

 

 

 

 

Restricted stock awards

 

 -

 

 

 -

Employee stock options

 

 -

 

 

 -

Other equity-based awards

 

 -

 

 

 -

Weighted-average number of shares outstanding — diluted

 

112,291,496 

 

 

111,252,331 



 

 

 

 

 

The Company generated a loss from continuing operations attributable to Community Health Systems, Inc. common stockholders for the three months ended March 31, 2018 and 2017, so the effect of dilutive securities is not considered because their effect would be antidilutive. If the Company had generated income from continuing operations, the effect of restricted stock awards on the diluted shares calculation would have been an increase of 73,361 shares and 78,773 shares during the three months ended March 31, 2018 and 2017, respectively.









 

 

 

 

 



 

 

 

 

 

 

Three Months Ended



March 31,

 

2018

 

2017

Dilutive securities outstanding not included in

 

 

 

 

 

the computation of earnings per

 

 

 

 

 

share because their effect is antidilutive:

 

 

 

 

 

Employee stock options and restricted stock awards

 

1,920,349 

 

 

3,507,729